查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463082

蛇抗毒素市場,佔有率,規模,趨勢,產業分析報告:依類型、作用機制、最終用戶、地區、細分市場預測，2024-2032

Snake Antivenom Market Share, Size, Trends, Industry Analysis Report, By Type (Polyvalent Heterologous, Monovalent Heterologous, Homologous, and Small Molecule Anti-Toxins); By Mode of Action; By End User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research最新研究顯示，到2032年，全球蛇抗蛇毒血清市場規模預計將達到6.3685億美元。該報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

蛇咬傷作為各地區常見的公共衛生問題，其發病率不斷上升，增加了對有效的毒液中和解決方案和治療方法的需求，推動了市場的成長。醫療保健專業人員對蛇咬傷的識別、管理和治療的認識正在推動抗蛇毒血清藥物的需求。此外，研究和開發的進步促使開發出更有效的抗蛇毒血清製劑以及診斷和治療方法的進步預計將進一步推動市場成長。

例如，2023年1月，Ophirex Inc.宣佈完成3,700萬美元B輪融資。這筆資金將用於繼續臨床開發和監管提交，以推進廣泛的蛇咬傷治療。

提供有效、安全和高品質的特有物種專用產品已成為減少蛇咬傷負擔的重要因素。從國家層級來看，抗蛇毒血清產量不足以滿足臨床需求，尤其是抗蛇毒血清生產不良的地區。因此，增強抗蛇毒血清生產或開發能力的新機會正在出現，這也是市場成長的好兆頭。

例如，《Indian Journal of Medical Research》2023 年 4 月發表的一份報告發現，印度致力於制定一項國家蛇咬傷預防和控制計劃，並鼓勵開發新型有效的抗蛇毒血清。

此外，人們越來越關注蛇抗蛇毒血清領域的研究和開發活動，其中主要包括開發新的和改進的治療製劑以及改善整體治療結果等活動。這將有助於患者迅速從疼痛中恢復，並減少世界各地不斷增加的蛇咬傷死亡人數。

蛇抗蛇毒血清市場報告亮點

多價異質藥物部分佔最大佔有率。

由於神經毒性蛇咬傷的盛行率不斷上升以及醫療保健專業人員的採用，神經毒性部分佔據了最大佔有率。

由於患者人數大幅增加和醫院基礎設施的改善，醫院和診所部門將以最快的速度成長。

由於蛇咬傷事件數量不斷增加，死亡人數不斷增加，預計亞太地區將主導全球市場。

主要市場參與者包括Boehringer Ingelheim Thermo Fisher, Hamilton Company, Incepta vaccine, Novo Nordisk, rare disease treatment, Bioclon。

目錄

第一章簡介

第二章執行摘要

第三章研究方法論

第四章全球蛇抗蛇毒血清市場洞察

  • 蛇抗蛇毒血清市場 – 最終用戶快照
  • 蛇抗蛇毒血清市場動態
    • 驅動因素和機遇
      • 蛇咬傷事件增加，研發活動投資增加
      • 政府措施和資金
    • 限制因素和課題
      • 抗蛇毒血清生產成本高
  • PESTEL 分析
  • 蛇抗蛇毒血清市場最終用戶趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第五章依類型劃分的世界市場

  • 主要發現
  • 介紹
  • 多價異質
  • 單價異質
  • 相同的
  • 小分子

第六章全球市場的作用機制

  • 主要發現
  • 介紹
  • 細胞毒性
  • 神經毒性
  • 血液毒性
  • 心臟毒性
  • 肌肉毒性
  • 其他

第七章最終用戶的全球市場

  • 主要發現
  • 介紹
  • 醫院/診所
  • 門診手術中心
  • 研究機構
  • 其他

第八章依地區劃分的世界市場

  • 主要發現
  • 介紹
    • 蛇抗毒素市場評估，依地區，2019-2032
  • 蛇抗蛇毒血清市場－北美
    • 北美：蛇抗蛇毒血清市場，依類型，2019-2032
    • 北美：蛇抗蛇毒血清市場，依最終用戶劃分，2019-2032 年
    • 北美：蛇抗毒素市場，依作用機制，2019-2032
    • 蛇抗蛇毒血清市場—美國
    • 蛇抗蛇毒血清市場—加拿大
  • 蛇抗蛇毒血清市場—歐洲
    • 歐洲：蛇抗蛇毒血清市場，依類型，2019-2032
    • 歐洲：蛇抗蛇毒血清市場，依最終用戶劃分，2019-2032 年
    • 歐洲：蛇抗蛇毒血清市場，依作用機制，2019-2032
    • 蛇抗蛇毒血清市場—英國
    • 蛇抗蛇毒血清市場—法國
    • 蛇抗蛇毒血清市場—德國
    • 蛇抗蛇毒血清市場—義大利
    • 蛇抗蛇毒血清市場—西班牙
    • 蛇抗蛇毒血清市場—荷蘭
    • 蛇抗蛇毒血清市場—俄羅斯
  • 蛇毒血清市場 – 亞太地區
    • 亞太地區：蛇抗蛇毒血清市場，依類型，2019-2032
    • 亞太地區：蛇抗蛇毒血清市場，依最終用戶劃分，2019-2032 年
    • 亞太地區：蛇抗蛇毒血清市場（依作用機制），2019-2032 年
    • 蛇抗蛇毒血清市場—中國
    • 蛇抗蛇毒血清市場—印度
    • 蛇毒血清市場 – 馬來西亞
    • 蛇抗蛇毒血清市場—日本
    • 蛇抗蛇毒血清市場-印度尼西亞
    • 蛇抗蛇毒血清市場－韓國
  • 蛇抗蛇毒血清市場 - 中東和非洲
    • 中東和非洲：蛇抗蛇毒血清市場，依類型，2019-2032
    • 中東和非洲：蛇抗蛇毒血清市場，依最終用戶劃分，2019-2032 年
    • 中東和非洲：蛇抗毒素市場，依作用機制，2019-2032
    • 蛇抗蛇毒血清市場-沙烏地阿拉伯
    • 蛇抗蛇毒血清市場 - 阿聯酋
    • 蛇抗蛇毒血清市場—以色列
    • 蛇毒血清市場—南非
  • 蛇毒血清市場—拉丁美洲
    • 拉丁美洲：蛇抗蛇毒血清市場，依類型，2019-2032
    • 拉丁美洲：蛇抗蛇毒血清市場，依最終用戶劃分，2019-2032 年
    • 拉丁美洲：蛇抗蛇毒血清市場（依作用機制），2019-2032 年
    • 蛇抗蛇毒血清市場—墨西哥
    • 蛇抗蛇毒血清市場－巴西
    • 蛇抗蛇毒血清市場—阿根廷

第9章 競爭格局

  • 擴張和收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/出版物

第十章公司簡介

  • Bharat Serums and Vaccine Limited
  • Bioclon Institute
  • Boehringer-Ingelheim Thermo Fisher
  • Boston Scientific Corporation
  • BTG International Inc.
  • CSL Limited
  • Hamilton Company
  • Incepta Vaccine Ltd.
  • Inosan Biopharma
  • Merck & Co. Inc.
  • MicroPharm
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • Rare Disease Therapeutics Inc.
  • VINS Bioproducts Limited
Product Code: PM4444

The global snake antivenom market size is expected to reach USD 636.85 Million by 2032, according to a new study by Polaris Market Research. The report "Snake Antivenom Market Share, Size, Trends, Industry Analysis Report, By Type (Polyvalent Heterologous, Monovalent Heterologous, Homologous, and Small Molecule Anti-Toxins); By Mode of Action; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of snakebites as a common public health issue across various regions and increased demand for effective venom neutralizing solutions or treatments, driving the market's growth. Awareness among healthcare professionals about the identification, management, and treatment of snakebites, fostering the demand for antivenoms. Additionally, growing advances in R&D that results in the creation of more effective antivenom formulations and advancements in diagnostics and treatment methods, are further anticipated to boost market's growth.

For instance, in January 2023, Ophirex Inc., announced that they completed a USD 37 million Series B financing. The funds will be used to continue clinical development and regulatory submission in order to advance broad-spectrum snakebite treatment.

The access to effective, safe, and quality products that are specially tailored to the endemic species has been becoming an important component to reduce the burden of snake bites. At the national level, there is insufficient manufacturing output of antivenoms to meet the clinical needs especially for antivenoms intended for use in region with scarcity of producers. Thus, there is an emerging opportunity for manufacturing or developing antivenoms with enhanced capabilities, which will also bode well for market's growth.

For instance, according to a report published by the Indian Journal of Medical Research in April 2023, India is focusing on a national programme for prevention & control of snakebite in India that encourages the development new and effective antivenoms.

Furthermore, there is a growing emphasis on research & development activities in the field of snake antivenom which mainly includes activities like creation of new improved treatment formulations and improving the overall treatment outcomes. It helps patients quickly recover from the pain and reduces the number of constantly rising deaths due to snakebites across the globe.

Snake Antivenom Market Report Highlights

Polyvalent heterologous segment accounted for the largest share, due to its higher effectiveness and preference over alternative options

Neurotoxic segment held the maximum share, on account of rising prevalence of neurotoxic snakebites and its adoption among healthcare professionals

Hospitals & clinics segment will grow at fastest pace, owing to significant increase in patient population and improvements in hospitals infrastructure

Asia Pacific is expected to dominated the global market, due to rising incidences of snakebites and number of deaths occurs due to thus in the region

The key market players include Boehringer-Ingelheim Thermo Fisher, Hamilton Company, Incepta Vaccine, Novo Nordisk, Rare Disease Therapeutics, and Bioclon

Polaris Market Research has segmented the snake antivenom market report based on type, mode of action, end user, and region:

Snake Antivenom, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Polyvalent Heterologous
  • Monovalent Heterologous
  • Homologous
  • Small Molecule Anti-Toxins

Snake Antivenom, Mode of Action Outlook (Revenue - USD Million, 2019 - 2032)

  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic
  • Others

Snake Antivenom, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Others

Snake Antivenom, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Snake Antivenom Market Insights

  • 4.1. Snake Antivenom Market - End User Snapshot
  • 4.2. Snake Antivenom Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing incidences of snakebites and rising investments on R&D activities spurring the global market growth.
      • 4.2.1.2. Government Initiatives and Funding.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs of Antivenom Production.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Snake Antivenom Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Snake Antivenom Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • 5.3. Polyvalent Heterologous
    • 5.3.1. Global Snake Antivenom Market, by Polyvalent Heterologous, by Region, 2019-2032 (USD Million)
  • 5.4. Monovalent Heterologous
    • 5.4.1. Global Snake Antivenom Market, by Monovalent Heterologous, by Region, 2019-2032 (USD Million)
  • 5.5. Homologous
    • 5.5.1. Global Snake Antivenom Market, by Homologous, by Region, 2019-2032 (USD Million)
  • 5.6. Small Molecule
    • 5.6.1. Global Snake Antivenom Market, by Small Molecule, by Region, 2019-2032 (USD Million)

6. Global Snake Antivenom Market, by Mode of Action

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 6.3. Cytotoxic
    • 6.3.1. Global Snake Antivenom Market, by Cytotoxic, by Region, 2019-2032 (USD Million)
  • 6.4. Neurotoxic
    • 6.4.1. Global Snake Antivenom Market, by Neurotoxic, by Region, 2019-2032 (USD Million)
  • 6.5. Haemotoxic
    • 6.5.1. Global Snake Antivenom Market, by Haemotoxic, by Region, 2019-2032 (USD Million)
  • 6.6. Cardiotoxic
    • 6.6.1. Global Snake Antivenom Market, by Cardiotoxic, by Region, 2019-2032 (USD Million)
  • 6.7. Myotoxic
    • 6.7.1. Global Snake Antivenom Market, by Myotoxic, by Region, 2019-2032 (USD Million)
  • 6.8. Others
    • 6.8.1. Global Snake Antivenom Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Snake Antivenom Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global Snake Antivenom Market, by Hospitals & Clinics, By Region, 2019-2032 (USD Million)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Global Snake Antivenom Market, by Ambulatory Surgical Centers, By Region, 2019-2032 (USD Million)
  • 7.5. Research Institutes
    • 7.5.1. Global Snake Antivenom Market, by Research Institutes, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Snake Antivenom Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Snake Antivenom Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Snake Antivenom Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Snake Antivenom Market - North America
    • 8.3.1. North America: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.3.4. Snake Antivenom Market - U.S.
      • 8.3.4.1. U.S.: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.3.5. Snake Antivenom Market - Canada
      • 8.3.5.1. Canada: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 8.4. Snake Antivenom Market - Europe
    • 8.4.1. Europe: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.4. Snake Antivenom Market - UK
      • 8.4.4.1. UK: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.5. Snake Antivenom Market - France
      • 8.4.5.1. France: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.6. Snake Antivenom Market - Germany
      • 8.4.6.1. Germany: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.7. Snake Antivenom Market - Italy
      • 8.4.7.1. Italy: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.8. Snake Antivenom Market - Spain
      • 8.4.8.1. Spain: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.9. Snake Antivenom Market - Netherlands
      • 8.4.9.1. Netherlands: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.10. Snake Antivenom Market - Russia
      • 8.4.10.1. Russia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 8.5. Snake Antivenom Market - Asia Pacific
    • 8.5.1. Asia Pacific: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.4. Snake Antivenom Market - China
      • 8.5.4.1. China: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.5. Snake Antivenom Market - India
      • 8.5.5.1. India: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.6. Snake Antivenom Market - Malaysia
      • 8.5.6.1. Malaysia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.7. Snake Antivenom Market - Japan
      • 8.5.7.1. Japan: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.8. Snake Antivenom Market - Indonesia
      • 8.5.8.1. Indonesia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.9. Snake Antivenom Market - South Korea
      • 8.5.9.1. South Korea: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 8.6. Snake Antivenom Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.6.4. Snake Antivenom Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.6.5. Snake Antivenom Market - UAE
      • 8.6.5.1. UAE: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.6.6. Snake Antivenom Market - Israel
      • 8.6.6.1. Israel: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.6.7. Snake Antivenom Market - South Africa
      • 8.6.7.1. South Africa: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 8.7. Snake Antivenom Market - Latin America
    • 8.7.1. Latin America: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.7.4. Snake Antivenom Market - Mexico
      • 8.7.4.1. Mexico: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.7.5. Snake Antivenom Market - Brazil
      • 8.7.5.1. Brazil: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.7.6. Snake Antivenom Market - Argentina
      • 8.7.6.1. Argentina: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bharat Serums and Vaccine Limited
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bioclon Institute
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer-Ingelheim Thermo Fisher
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Boston Scientific Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. BTG International Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. CSL Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hamilton Company
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Incepta Vaccine Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Inosan Biopharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck & Co. Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. MicroPharm
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Novo Nordisk A/S
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Owen Mumford Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Pfizer Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Rare Disease Therapeutics Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. VINS Bioproducts Limited
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development

List of Tables

  • Table 1 Global Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 3 Global Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 4 Snake Antivenom Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 6 North America: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 7 North America: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 10 U.S.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 12 Canada: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 13 Canada: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 15 Europe: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 16 Europe: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 18 UK: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 19 UK: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 21 France: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 22 France: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 24 Germany: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 25 Germany: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 27 Italy: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 28 Italy: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 30 Spain: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 31 Spain: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 34 Netherlands: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 36 Russia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 37 Russia: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 42 China: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 43 China: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 45 India: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 46 India: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 49 Malaysia: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 51 Japan: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 52 Japan: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 55 Indonesia: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 58 South Korea: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 66 UAE: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 67 UAE: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 69 Israel: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 70 Israel: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 73 South Africa: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 76 Latin America: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 79 Mexico: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 82 Brazil: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 85 Argentina: Snake Antivenom Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Snake Antivenom Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Mode of Action
  • Figure 7. Global Snake Antivenom Market, by Mode of Action, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Snake Antivenom Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Snake Antivenom Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Snake Antivenom Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Snake Antivenom Market